SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-069112
Filing Date
2024-06-06
Accepted
2024-06-06 16:31:02
Documents
14
Period of Report
2024-05-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416569d1_8k.htm   iXBRL 8-K 31693
2 EXHIBIT 16.1 tm2416569d1_ex16-1.htm EX-16.1 2833
  Complete submission text file 0001104659-24-069112.txt   208662

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20240531.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20240531_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20240531_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416569d1_8k_htm.xml XML 3558
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 241025910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)